CORMEDIX INC.
Income Statement
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $224.1K | $210.1K | $189.3K | $2.0K | $0 |
| Cost of Revenue | $366.7K | $-318.7K | $-445.8K | $-201.6K | $0 |
| Gross Profit | $-142.6K | $-108.6K | $-256.5K | $-199.6K | $0 |
| Gross Margin | -63.6% | -51.7% | -135.5% | -9,975.2% | — |
| Operating Expenses | |||||
| Research & Development | $15.7M | $6.3M | $1.3M | $1.2M | $1.1M |
| SG&A Expense | $8.9M | $10.3M | $7.3M | $3.5M | $1.9M |
| Operating Income | $-24.8M | $-16.7M | $-8.9M | $-4.9M | $-3.0M |
| Operating Margin | -11,048.8% | -7,925.6% | -4,703.3% | -245,646.9% | — |
| Interest Expense | $1.3K | $4.0K | $2.1K | $1.4M | $382.9K |
| Pretax Income | $-24.6M | $-18.2M | $-20.5M | $-9.1M | $-3.4M |
| Income Tax Expense | — | — | — | $0 | $0 |
| Net Income | $-24.6M | $-18.2M | $-20.5M | $-9.1M | $-3.4M |
| Net Margin | -10,996.5% | -8,655.4% | -10,806.3% | -456,426.7% | — |
| EPS (Basic) | $-0.65 | $-0.58 | $-0.96 | $-0.69 | $-0.30 |
| EPS (Diluted) | $-0.65 | $-0.58 | $-0.96 | $-0.69 | $-0.30 |
| Shares Outstanding (Basic) | 40.4M | 36.0M | 22.5M | 16.6M | 11.4M |
| Shares Outstanding (Diluted) | 40.4M | 36.0M | 22.5M | 16.6M | 11.4M |
| Dividends Per Share | — | — | — | — | — |